Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2400Neoplasms 1817Carcinoma, Non-Small-Cell Lung 1598Prostatic Neoplasms 1306Colorectal Neoplasms 1139Lung Neoplasms 985Neoplasm Metastasis 836Multiple Myeloma 794Leukemia, Myeloid, Acute 767Ovarian Neoplasms 677Pancreatic Neoplasms 662Melanoma 660Squamous Cell Carcinoma of Head and Neck 584Carcinoma, Hepatocellular 571Recurrence 564Brain Neoplasms 528Glioblastoma 515Head and Neck Neoplasms 503Stomach Neoplasms 498Triple Negative Breast Neoplasms 465Lymphoma 456Uterine Cervical Neoplasms 453Carcinoma, Renal Cell 424Precursor Cell Lymphoblastic Leukemia-Lymphoma 408Lymphoma, Non-Hodgkin 390Endometrial Neoplasms 384Sarcoma 371Lymphoma, Follicular 358Urinary Bladder Neoplasms 355Hematologic Neoplasms 355

Interventions

Bumetanide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Unresectable Hepatocellular Carcinoma × 1 year × Clear all
NCT03107416 2026-05-05

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT07351513 2026-01-20

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 2 Not yet recruiting
94 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡